Patient Guide: A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 23 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07073079
Status: 🟢 Enrolling Now
Condition: Crohn's Disease
Phase: Not Specified

Find a Study Location Near You

This study is available at 23 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Castellana Grotte, Bari
  • Monserrato, Cagliari
  • San Giovanni Rotondo, Foggia
  • • And 20 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily